Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Regeneron Pharmaceuticals
Related studies linked through entity extraction aliases.
NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions
- Status
- COMPLETED
- Phase
- PHASE4
Using Aflibercept Injection to Treat Blood Vessel Growth Over the Cornea
- Status
- TERMINATED
- Phase
- PHASE1
Study of Dupilumab Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis
- Status
- COMPLETED
- Phase
- PHASE2
Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy
- Status
- UNKNOWN
- Phase
- PHASE4
An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma
- Status
- COMPLETED
- Phase
- PHASE2
Single Ascending Dose Study of Safety and Tolerability of Sarilumab and Methotrexate in Japanese Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE1
Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Efficacy and Safety Evaluation of Alirocumab (SAR236553/REGN727) in Patients With Primary Hypercholesterolemia on Stable Atorvastatin Therapy in Japan
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate the Safety and Tolerability of Two Doses of Rilonacept in Pediatric Subjects With Active Systemic Juvenile Idiopathic Arthritis (SJIA)
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetic of Alirocumab SAR236553 (REGN727) Administered Subcutaneously at 3 Different Injection Sites in Healthy Subjects
- Status
- COMPLETED
- Phase
- PHASE1
Eylea Post Marketing Surveillance(PMS)
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of VEGF Trap Eye in Diabetic Macular Edema (DME) With Central Involvement
- Status
- COMPLETED
- Phase
- PHASE3
Repeated Eye Injections of Aflibercept for Treatment of Wet Age Related Macular Degeneration
- Status
- COMPLETED
- Phase
- NA
Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy
- Status
- COMPLETED
- Phase
- N/A
To Evaluate The Safety of SAR153191 (REGN88) and Tocilizumab Added to Other RA Drugs in Patients With RA Who Are Not Responding to or Intolerant of Anti-TNF Therapy (SARIL-RA-ASCERTAIN)
- Status
- COMPLETED
- Phase
- PHASE3
An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate
- Status
- TERMINATED
- Phase
- PHASE3
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
- Status
- COMPLETED
- Phase
- N/A
EYLEA Age-Related Macular Degeneration (AMD) Post-marketing Surveillance in Japan
- Status
- COMPLETED
- Phase
- N/A
Study to Assess the Safety and Tolerability of Single Doses of REGN1500
- Status
- COMPLETED
- Phase
- PHASE1